Rhoen Klinikum AG
XETRA:RHK
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
9.55
13.3
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Rhoen Klinikum AG
Rhoen Klinikum AG
Total Equity
Rhoen Klinikum AG
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Rhoen Klinikum AG
XETRA:RHK
|
Total Equity
€1.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
1%
|
|
|
M1 Kliniken AG
XETRA:M12
|
Total Equity
€136.4m
|
CAGR 3-Years
14%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Mediclin AG
XETRA:MED
|
Total Equity
€212.2m
|
CAGR 3-Years
6%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
|
MATERNUS-Kliniken-AG
XETRA:MAK
|
Total Equity
-€55.6m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
-9%
|
|
|
Eifelhoehen-Klinik AG
F:EIF
|
Total Equity
€11.8m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
M
|
MedNation AG
SWB:EIF
|
Total Equity
€11.8m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
Rhoen Klinikum AG
Glance View
Rhön-Klinikum AG engages in the provision of healthcare services. The company is headquartered in Bad Neustadt An Der Saale, Bayern and currently employs 18,227 full-time employees. The company operates acute hospitals, medical care centers and rehabilitation hospitals across Germany: six clinics on Campus Bad Neustadt, including the Cardiovascular Clinic, the Frankenklinik for the Rehabilitation of Cardiovascular Patients, the Clinic for Hand Surgery, the Neurological Clinic, the Psychosomatic Clinic and the Saaletalklinik with two additional addiction therapy facilities; Klinikum Frankfurt (Oder) comprises clinics, psychiatric outpatient institutions and day clinics; University Hospital Giessen and Marburg (UKGM) offers medical services, modern diagnostics and comprehensive therapy in various areas, including ophthalmology, trauma surgery and dentistry, and Zentralklinik Bad Berka provides health care services to patients with thoracic, pulmonary and vascular diseases, tumors, neurological conditions, and diseases of the spinal column, joints and heart, among others.
See Also
What is Rhoen Klinikum AG's Total Equity?
Total Equity
1.3B
EUR
Based on the financial report for Sep 30, 2024, Rhoen Klinikum AG's Total Equity amounts to 1.3B EUR.
What is Rhoen Klinikum AG's Total Equity growth rate?
Total Equity CAGR 10Y
1%
Over the last year, the Total Equity growth was 4%. The average annual Total Equity growth rates for Rhoen Klinikum AG have been 3% over the past three years , 2% over the past five years , and 1% over the past ten years .
You don't have any saved screeners yet
